These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35544594)

  • 41. Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers.
    Galkowska H; Olszewsk WL; Wojewodzka U; Mijal J; Filipiuk E
    Surgery; 2003 Aug; 134(2):213-20. PubMed ID: 12947320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Negative pressure wound therapy, artificial skin and autogenous skin implantation in diabetic foot ulcers.
    Chia-Jui H; Yu L; Jiang YQ; Tan W; Gao GM; Li HB; Han L
    J Wound Care; 2022 Jan; 31(1):40-46. PubMed ID: 35077212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of chronic diabetic foot ulcers using platelet-rich plasma.
    Babaei V; Afradi H; Gohardani HZ; Nasseri F; Azarafza M; Teimourian S
    J Wound Care; 2017 Dec; 26(12):784-787. PubMed ID: 29244965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-200b/c-3p regulate epithelial plasticity and inhibit cutaneous wound healing by modulating TGF-β-mediated RAC1 signaling.
    Tang H; Wang X; Zhang M; Yan Y; Huang S; Ji J; Xu J; Zhang Y; Cai Y; Yang B; Lan W; Huang M; Zhang L
    Cell Death Dis; 2020 Oct; 11(10):931. PubMed ID: 33122632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic and molecular basis of diabetic foot ulcers: Clinical review.
    Jhamb S; Vangaveti VN; Malabu UH
    J Tissue Viability; 2016 Nov; 25(4):229-236. PubMed ID: 27372176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medicinal Plants as Efficacious Agents for Diabetic Foot Ulcers: A Systematic Review of Clinical Studies.
    Ahmadian R; Bahramsoltani R; Marques AM; Rahimi R; Farzaei MH
    Wounds; 2021 Aug; 33(8):207-218. PubMed ID: 34357879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOXM1 network in association with TREM1 suppression regulates NET formation in diabetic foot ulcers.
    Sawaya AP; Stone RC; Mehdizadeh S; Pastar I; Worrell S; Balukoff NC; Kaplan MJ; Tomic-Canic M; Morasso MI
    EMBO Rep; 2022 Aug; 23(8):e54558. PubMed ID: 35856334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained release of stromal cell derived factor-1 from an antioxidant thermoresponsive hydrogel enhances dermal wound healing in diabetes.
    Zhu Y; Hoshi R; Chen S; Yi J; Duan C; Galiano RD; Zhang HF; Ameer GA
    J Control Release; 2016 Sep; 238():114-122. PubMed ID: 27473766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model.
    Li X; Xie X; Lian W; Shi R; Han S; Zhang H; Lu L; Li M
    Exp Mol Med; 2018 Apr; 50(4):1-14. PubMed ID: 29651102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leveraging Potential of Nanotherapeutics in Management of Diabetic Foot Ulcer.
    Pandey S; Shaif M; Ansari TM; Shamim A; Kushwaha P
    Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):678-686. PubMed ID: 35240693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR193b Promotes Apoptosis of Gastric Cancer Cells via Directly Mediating the Akt Pathway.
    Tian R; Jiang H; Shao L; Yu Y; Guo Q; Cao B; Guo S
    Biomed Res Int; 2020; 2020():2863236. PubMed ID: 32596290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial.
    Arango-Rodríguez ML; Solarte-David VA; Becerra-Bayona SM; Callegari E; Paez MD; Sossa CL; Vera MEO; Mateus LC; Eduardo Serrano S; Ardila-Roa AK; Viviescas LTG
    Cytotherapy; 2022 Oct; 24(10):1035-1048. PubMed ID: 36084965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of different transplantations with bone-marrow derived mesenchymal stem cells on diabetic foot ulcers in rats].
    Wan J; Cai Q; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):347-55. PubMed ID: 23645234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers.
    Yammine K; Kheir N; Assi C
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of stem cells in the treatment of diabetic foot ulcers.
    Blumberg SN; Berger A; Hwang L; Pastar I; Warren SM; Chen W
    Diabetes Res Clin Pract; 2012 Apr; 96(1):1-9. PubMed ID: 22142631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated Skin Transcriptomics and Serum Multiplex Assays Reveal Novel Mechanisms of Wound Healing in Diabetic Foot Ulcers.
    Theocharidis G; Baltzis D; Roustit M; Tellechea A; Dangwal S; Khetani RS; Shu B; Zhao W; Fu J; Bhasin S; Kafanas A; Hui D; Sui SH; Patsopoulos NA; Bhasin M; Veves A
    Diabetes; 2020 Oct; 69(10):2157-2169. PubMed ID: 32763913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary wound closure of diabetic foot ulcers by debridement and stitching.
    Ahmed ME; Mohammed MS; Mahadi SI
    J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chitosan-based dressings loaded with neurotensin--an efficient strategy to improve early diabetic wound healing.
    Moura LI; Dias AM; Leal EC; Carvalho L; de Sousa HC; Carvalho E
    Acta Biomater; 2014 Feb; 10(2):843-57. PubMed ID: 24121197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open-label, single-arm feasibility study in diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano R; Glat PM; Carter M; Zelen CM; Li WW
    Int Wound J; 2020 Oct; 17(5):1366-1375. PubMed ID: 32453512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.